You just read:

Synthetic Genomics Announces Collaboration with Johnson & Johnson Innovation to Develop Novel Therapeutics Using Synthetic Genomics' Replicon RNA Technology

News provided by

Synthetic Genomics, Inc.

Jan 05, 2017, 08:00 ET